ClinicalTrials.gg
RecruitingNCT05961813Updated Jul 27, 2023

Intervention for Smoking Cessation in Pre-Surgical Patients.

An interventional study of Intensive intervention for smoking cessation and Brief intervention for smoking cessation in Smoking, Smoking Cessation and Surgical Procedure, Unspecified, sponsored by Hospital Universitari Vall d'Hebron Research Institute. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-27.

Sponsored by Hospital Universitari Vall d'Hebron Research Institute · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
232
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Smoking with a site in Spain — 4 open to participants now, 5 under way, none of them phase 3. Smoking · Spain.

Planned enrollment
16th of 19
232 · median 408
Started
2023
with 2 others
No phase
15 of 27
4 open now
Registered
24th of 27
by date

Among the 27 studies in Smoking with a site in Spain, this one is the 16th largest by planned enrollment of the 19 interventional ones that give a count, is one of 3 that started in 2023, is one of 15 with no phase, and was the 24th registered.

Smoking

1,516 studies on the registry are indexed under Smoking; 196 are open to participants now.

Browse Smoking studies →

Open to participants now

4 of the 27 studies in Smoking with a site in Spain are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 145 Smoking studies recruiting now, 76 (52%) set no upper age limit and 51 (35%) stop at 75 or younger; 3 take children under 18; 69 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Smoking with a site in Spain, or all of them as a file.
02

Study summary

The goal of this clinical trial is to assess efficacy of an intensive pre-surgical intervention to quit smoking in smoking patients who will be operated on implant orthopedic surgery or general and urological surgery. The main question[s] it aims to answer are:

  • Evaluate the efficacy of intensive pre surgical intervention to quit smoking compared to a brief intervention
  • Evaluate the implementation of this protocol.

Participants will be randomized to 2 intervention groups (patients programmed for protesic implant orthopedic surgery in the first group, and general and urological surgery) and 2 control groups (stratified in the same manner as the intervention groups), and will be monitored through telematic check ups via phone calls.

Read the detailed description
  1. Subject recruitment in pre surgical anesthesiology consults, data collection and randomization within 48 hours of said visit.
  2. Subjects in the intensive intervention group will be sent to a specialized Preventive Medicine consult for smoking cessation, completing 6 visits (2 before surgical intervention, 4 visits withint the following 12 months). Subjects in the control group will receive brief advice on quitting smoking through a phone call the the same day randomization is performed. Both groups will receive follow up calls at months 1, 3, 6, and 12, after surgical intervetion. All patients will have their smoking habits evaluated and the relevant data about the surgical intervention collected the day of the intervention.
  3. At month 7 adecuacy of the protocol will be evaluated to assess if any modifications are necessary.
  4. Data entry and quality control of the database will be performed periodically for the duration of the study.
03

Conditions studied

  • Smoking
  • Smoking Cessation
  • Surgical Procedure, Unspecified

Keywords

  • Smoking
  • Smoking Cessation
  • Tobacco Use Disorder
  • Surgery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients must 18 years old or older, and be able to consent.
  • Surgery programmed for at least 4 weeks after inclusion in the study.
  • Smokers

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Already under treatment for smoking cessation
  • Inability to consent due to cognitive impairment or language barrier.
  • Non-primary knee or hip replacement surgery
  • Participation in any study that forbids use of nicotine substitution therapy (dermal, oral)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
232 participants (estimated)

Study arms

  • Experimental
    Intervention group in protesic implant orthopedic surgery

    58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will be sent to a specialized preventive medicine consult to quit smoking.

    Behavioral: Intensive intervention for smoking cessation

  • Experimental
    Intervention group in general and urological surgery

    58 patients programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will be sent to a specialized preventive medicine consult to quit smoking.

    Behavioral: Intensive intervention for smoking cessation

  • Active comparator
    Control group in protesic implant orthopedic surgery

    58 patients programmed for knee or hip replacement surgeries, or spinal arthrodesis surgery who will receive a brief intervention for smoking cessation.

    Behavioral: Brief intervention for smoking cessation

  • Active comparator
    Control group in general and urological surgery

    58 programmed for colorrectal surgery due to colorrectal cancer, cistectomy, radical prostatectomy and partial or total nefrectomy, who will receive a brief intervention for smoking cessation.

    Behavioral: Brief intervention for smoking cessation

Interventions

  • BehavioralIntensive intervention for smoking cessation

    Patients will be given a brochure and presentation on smoking cessation and will complete 6 visits (2 before surgical intervention, 4 visits within the following 12 months), as well as follow up phone calls for progressi monitorization.

  • BehavioralBrief intervention for smoking cessation

    Patients will be given a brochure and presentation on smoking cessation 4 weeks before surgery, as well as follow up phone calls for progressi monitorization.

06

What researchers measure

Primary outcomes

  1. Tobacco use

    Change in self reported tobacco use (smoking)

    Time frame: Evaluated at 1, 3, 6, and 12 months after surgical intervention

Secondary outcomes

  1. Changes in concentration of exhaled CO measured with a CO-oximeter

    A patient will be considered as an active tobacco user if more than 6 of carboxyhemoglobin particles per million are found through the use of a CO-oximeter

    Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

  2. Changes in rate of different type of tobbaco product users

    Cigarettes, cigars, rolling tobacco, etc.

    Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

  3. Changes in tobacco use pattern

    Amount and frequency (daily, weekly, sporadically)

    Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

  4. Changes in degree of nicotine dependency

    Fagerström test \[low dependency (0-3), medium dependency (4-6), y high dependency (7-10)\]

    Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

  5. Changes in disposition to smoking cessation

    Prochaska and Di Clemente's model (pre contemplation, contemplation, preparation, action, maintenance or relapse)

    Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

  6. Changes in Motivation level

    Richmond's test (\<3 no motivation; 4-5 doubtful motivation; 6-7 moderate motivation; 8-10 high motivation)

    Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

  7. Changes in self-efficacy

    Albert Bandura's social cognitive theory

    Time frame: Evaluated at recruitment, and 1, 3, 6, and 12 months after surgical intervention

  8. Number of patients with surgical complicatoins

    Complications will be classified as respiratory, cardiovascular, surgical wound and complications, mortality

    Time frame: Hospitalization period and 90 days after surgical intervention.

  9. Surgery duration

    Time spent in the operation room

    Time frame: Day of intervention

  10. Need of blood transfusion

    Volume of blood transfused during surgery

    Time frame: Day of intervention

  11. Hospitalization duration

    Number of days of hospitalization after surgery.

    Time frame: Days from admitting until discharge.

  12. Need of new hospitalizations

    Number of times patient is admitted to the hospital during follow up

    Time frame: 12 months after surgical intervention.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Jun 2025, 24 months after the start.

Of 405 non-industry interventional studies with no phase under Smoking, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 24 months is close to that.

Counting every sponsor, half of 461 studies reached it within 23 months; a quarter within 8 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2023
First posted
Jul 27, 2023
StartActual
May 20, 2023
Primary completionEst.
Jun 1, 2025
CompletionEst.
Jan 1, 2026
Last update
Jul 27, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05961813
Responsible party
Sponsor
First posted
Jul 27, 2023
Start date
May 20, 2023
Primary completion
Jun 1, 2025 (estimated)
Completion
Jan 1, 2026 (estimated)
Last update
Jul 27, 2023

Study contacts

Eva Gavilán Castillo, RN; MSN
Contact
eva.gavilan@vallhebron.cat
934893000 ext. 8021
Eva Gavilán Castillo, RN; MSN
principal investigator · Vall d'Hebron Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion